Science
Mechanism of Action
Cannabinoids interface with CB1 and CB2 receptors within the skin's endocannabinoid system (ECS). CBD functions as a 'sebostatic' modulator, utilizing the TRPV4/MAPK/Erk pathway to inhibit excess lipid production in sebocytes. Furthermore, it downregulates pro-inflammatory cytokines such as IL-1b and TNF-alpha via the JAK-STAT pathway while providing antioxidant protection superior to vitamins C and E.
Research
Clinical Evidence
High confidence3%
Key findings
- 01 A 3% concentration significantly reduced sebum production and facial redness over a 12-week period.
- 02 High-dose formulations (30% CBD/5% CBG) demonstrated marked improvements in transepidermal water loss (TEWL) and hydration for compromised barriers.
Transparency
Dusting Analysis
Due to high raw material costs and marketing allure, many products include cannabinoids at 'trace' levels (below 0.1%) which may provide antioxidant benefits but fail to trigger the sebostatic or significant anti-inflammatory responses seen in clinical data.
The Formula
Formulation
Stability
CBD is highly sensitive to photo-oxidation and thermal degradation. It requires airtight, opaque packaging and must be maintained within a strict pH range of 4.0–6.0 to prevent conversion into other cannabinoids like THC.
Synergies
- Terpenes
- Ceramides
- Squalane
- Bisabolol
Conflicts
- Strong oxidizing agents
- Extreme pH environments
- UV light
- High-heat processing
Safety
Safety Profile
While clinical studies use high percentages, the SCCS currently suggests a conservative 0.19% limit for leave-on products. THC impurities must strictly remain below 0.00025% for cosmetic compliance.
Your Skin
Skin Compatibility
Our Assessment
Verdict
A sophisticated, multi-functional ingredient that excels at calming inflammation and balancing oil production when formulated with precision stability.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources